Jessica has handled both jury and non-jury trials and injunction proceedings in federal and state courts and has extensive experience in extraordinary writ practice and appeals before California and federal courts.
Additionally, she has advised clients in the computer industry and various manufacturing and service fields on trademark, copyright and antitrust issues, including issues relating to domain name use on the Internet. She has handled cases for major franchisers in the automotive service and home health care industries as well as state and federal antitrust actions against Microsoft and many television and movie studios. Recently, Jessica has had primary responsibility for large consumer class actions settlements arising from antitrust litigation against Microsoft.
Before joining Orrick, Jessica was a shareholder at Heller Ehrman LLP. She was Managing Partner of that firm from 1992 to 1995 and Chair of the Promotion Evaluation Committee from 2001 to 2007.
She also counsels clients on antitrust-related topics throughout the deal process, including providing guidance on pre-closing diligence, information sharing, and planning.
Additionally, Kristin’s experience includes consideration of foreign merger control filing requirements, preparing responses to government-issued requests for information and advising more generally on antitrust compliance considerations and policies.
Ryan focuses on representing borrowers and lenders in loan origination financing (in mortgage, auto, consumer and other loans, including warehouse and repurchase facilities) and servicing advance financing, acquisition financing (including mortgage servicing rights), syndicated financing, fund financing, working capital financing, litigation financing and asset based financing. He also assists clients with obtaining required applicable agency approvals in connection with these transactions.
Prior to joining Orrick, Ryan was a partner at Buckley LLP. He also was a corporate and securities associate in private practice, where he represented clients in a broad range of local, national and international corporate transactions.
Working with clients on the acquisitions of mortgage lending and money service business platforms, including obtaining the necessary approvals from federal and state licensing regulators for various licensing amendments
Completing surveys on various licensing-related topics, including recordkeeping requirements, periodic reporting requirements, and licenses required to engage in the money transmission business or to make, broker, purchase, sell and service various loan products
Assisting clients with licensing through their lifecycle, including obtaining de novo licenses and agency approvals, assisting with licensee record amendments, annual renewals, and license surrender following sale of assets or termination of a business line
Advising clients with respect to state licensing and regulatory issues, including Nationwide Multistate Licensing System (NMLS) management issues and ongoing licensing maintenance issues
Prior to joining Orrick, Norma was senior counsel at Buckley LLP. She also previously served as the vice president of compliance and counsel for a fintech company.
Taylor represents clients at all stages of their life cycles and in a variety of technology and science-driven industries, including cleantech, SaaS, gaming, energy, hardware, entertainment, Internet, media, semiconductor and media.
Taylor has experience drafting commercial, licensing and other intellectual property and technology agreements. She also assists clients with intellectual property issues in connection with a range of large commercial transactions, including mergers and acquisitions and strategic investments
Georgia also has extensive experience in assisting clients with product recalls, crisis management and government enforcement. Her practice in this sector includes assisting manufacturers, distributors, retailers and importers on all types of FDA regulated products including pharmaceuticals, medical devices and software, wearables, health and wellness products, cosmetics, cell and plant based foods, conventional foods, ag tech, compounded drugs, and dietary supplements.
Georgia’s deep experience and ability to provide practical guidance in FDA and FDA-adjacent regulatory matters allows her to work closely with innovative companies looking to minimize regulatory burdens and maximize U.S. marketing opportunities in the life science and health tech industry verticals. She also conducts regulatory due diligence for private equity and public company transactions involving life science, medtech and innovative companies.
Georgia is a frequent speaker at conferences and events who contributes regularly to leading trade and consumer media outlets.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.